Bausch Health Companies Inc. (BHC) News
Track canonical SquawkNews coverage tagged to BHC, Bausch Health Companies Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 15 indexed stories across 9 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket
Shares of Tempest Therapeutics Inc (NASDAQ: TPST ) rose sharply in pre-market trading after the California-based clinical-stage biotechnology company announced an exclusive option agreement with Hebei Senlang Biotechnolo
LIVE | Sep 16, 2026, 09:04 AM UTC
L
Bausch Health and Yun Lee expand strategic collaboration in Mexico, EMEA
Bausch Health Companies and Yun Lee Marine Group Holdings Ltd said they are expanding their strategic collaboration in Mexico and the EMEA markets.
EQUITY | Sep 08, 2026, 12:13 PM UTC
L
BHC - Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets
BHC - Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets
EQUITY | Sep 08, 2026, 12:02 PM UTC
L
Bausch Health and YUN expand Mexico and additional EMEA skincare markets
Bausch Health and YUN said their collaboration will expand access to science-led, microbiome-friendly skincare solutions in Mexico and add new EMEA markets, including launches in the Czech Republic, Slovakia, Ukraine, Bu
GEOPOLITICS | Sep 08, 2026, 12:01 PM UTC
L
Bausch Health reports new real-world research on enVista Aspire
Bausch + Lomb said it has published new research on real-world experience with enVista Aspire and enVista Aspire toric intraocular lenses (IOLs).
EQUITY | Sep 02, 2026, 11:00 AM UTC
L
Bausch Health announces Fraxel FTX availability in Australia
Bausch Health said Solta Medical’s Fraxel FTX is now available in Australia.
EQUITY | Sep 01, 2026, 12:01 PM UTC
L
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced findings from a new survey highlighting a significant awareness gap a
EQUITY | Sep 01, 2026, 10:58 AM UTC
L
Bausch Health announces Fraxel FTX availability in Australia
Bausch Health said Solta Medical’s Fraxel FTX® is now available in Australia.
EQUITY | Aug 31, 2026, 10:00 PM UTC
L
BHC - Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners
BHC - Bausch Health's Ortho Dermatologics Announces the 2026 Aspire Higher Scholarship Winners
EQUITY | Aug 27, 2026, 12:02 PM UTC
L
BHC - Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners
BHC - Bausch Health Announces 2026 Gastrointestinal Health Scholars Program Winners
EQUITY | Aug 17, 2026, 12:00 PM UTC
L
Bausch Health Companies Raises FY2026 Sales Guidance from $10.670B-$10.920B to $10.790B-$11.040B vs $10.773B Est
Bausch Health Companies (TSX: BHC ) raises FY2026 sales outlook from $10.670 billion-$10.920 billion to $10.790 billion-$11.040 billion vs $10.773 billion estimate.
EARNINGS | Jul 29, 2026, 08:13 PM UTC
L
BHC Bausch Health Companies Inc RESULTS: Q2, Q2 Net Income $260M, Q2 REV $2.852B, Q2 pretax profit $348M, Q2 Operating Income $740M, Q2 EPS
BHC Bausch Health Companies Inc RESULTS: Q2, Q2 Net Income $260M, Q2 REV $2.852B, Q2 pretax profit $348M, Q2 Operating Income $740M, Q2 EPS $0.68, Q2 ADJ EBITDA $1.075B, Bausch Health Companies Inc Earnings Notes:, Outlo
EARNINGS | Jul 29, 2026, 08:12 PM UTC
L
BHC Beats Q2 EPS, Sales Estimates
BHC reports Q2 EPS and sales above estimates
EARNINGS | Jul 29, 2026, 08:10 PM UTC
L
BHC - BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
BHC - BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE
EARNINGS | Jul 29, 2026, 08:06 PM UTC
L
Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement
Québec is the first province to list (Pr)OKEDI(MC) (ext
EQUITY | Jul 06, 2026, 11:00 AM UTC